Over the past 16 years, many researchers have proposed alterations in insulin levels or insulin signaling in people with late-onset Alzheimer's disease, recommending that people with Alzheimer's disease experience increased insulin levels and resistance to insulin in the brain. The gene discussed is INS; the disease is Alzheimer disease.